The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, M.-j.
Right arrow Articles by Maizels, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, M.-j.
Right arrow Articles by Maizels, N.
The Journal of Immunology, 1999, 163: 6659-6664.
Copyright © 1999 by The American Association of Immunologists

Activation and Targeting of Immunoglobulin Switch Recombination by Activities Induced by EBV Infection1

Ming-jie Li2,* and Nancy Maizels3,*,{dagger}

Departments of * Molecular Biophysics and Biochemistry and {dagger} Genetics, Yale University School of Medicine, New Haven, CT 06520

EBV is strongly associated with Burkitt’s lymphoma, a B cell malignancy. In certain types of Burkitt’s lymphoma, the c-myc gene has undergone translocation to the S regions associated with heavy chain switch recombination. It has not been established whether EBV infection induces recombination activities, which in turn promote translocation of c-myc, or whether translocation precedes viral infection and provides a growth advantage that is further enhanced by factors encoded or induced by the virus. To distinguish between these possibilities, we have compared the level of switch recombination activities in the EBV-negative lymphoma, BJAB, and in its EBV-infected derivative, BJAB-B1, in experiments that assayed recombination of an extrachromosomal switch substrate during transient transfection. We have found that BJAB-B1 and other EBV-positive B cell lines supported high levels of recombination of switch substrates, to produce junctions like those found in products of chromosomal switch recombination. In contrast, BJAB did not support comparable levels of switch substrate recombination. In EBV-positive B cell lines, the ability to support switch substrate recombination correlated with levels of LR1, a B cell-specific factor which is a transcriptional regulator of c-myc and which also appears to function in switch recombination. Our observations support the hypothesis that EBV infection can induce activities that affect switch recombination and thus contribute to the translocations of c-myc to the S regions that characterize certain classes of lymphomas.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. L. Wang and M. Wabl
DNA Acrobats of the Ig Class Switch
J. Immunol., May 15, 2004; 172(10): 5815 - 5821.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. He, N. Raab-Traub, P. Casali, and A. Cerutti
EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching
J. Immunol., November 15, 2003; 171(10): 5215 - 5224.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Sun, A. Yabuki, and N. Maizels
A human nuclease specific for G4 DNA
PNAS, October 23, 2001; 98(22): 12444 - 12449.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. A. Hanakahi and N. Maizels
Transcriptional activation by LR1 at the E{micro} enhancer and switch region sites
Nucleic Acids Res., July 15, 2000; 28(14): 2651 - 2657.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.